These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7737340)
21. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Nguyen VH; Kassiou M; Johnston GA; Christie MJ Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604 [TBL] [Abstract][Full Text] [Related]
22. The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia. Bath CP; Farrell LN; Gilmore J; Ward MA; Hicks CA; O'Neill MJ; Bleakman D Eur J Pharmacol; 1996 Mar; 299(1-3):103-12. PubMed ID: 8901012 [TBL] [Abstract][Full Text] [Related]
23. Characterization of the binding of [3H](+)-pentazocine to sigma recognition sites in guinea pig brain. DeHaven-Hudkins DL; Fleissner LC; Ford-Rice FY Eur J Pharmacol; 1992 Dec; 227(4):371-8. PubMed ID: 1359973 [TBL] [Abstract][Full Text] [Related]
24. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus. Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171 [TBL] [Abstract][Full Text] [Related]
25. In vitro characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino]cyclohexanol [(+)-pIV] as a sigma-1 receptor ligand. Shiba K; Ogawa K; Mori H Bioorg Med Chem; 2005 Feb; 13(4):1095-9. PubMed ID: 15670917 [TBL] [Abstract][Full Text] [Related]
26. (+)-[C-11]-cis-N-benzyl-normetazocine: a selective ligand for sigma receptors in vivo. Musachio JL; Scheffel U; Stathis M; Ravert HT; Mathews WB; Dannals RF Life Sci; 1994; 55(11):PL225-32. PubMed ID: 8072384 [TBL] [Abstract][Full Text] [Related]
27. Separation of alpha 1 adrenergic and N-methyl-D-aspartate antagonist activity in a series of ifenprodil compounds. Chenard BL; Shalaby IA; Koe BK; Ronau RT; Butler TW; Prochniak MA; Schmidt AW; Fox CB J Med Chem; 1991 Oct; 34(10):3085-90. PubMed ID: 1681106 [TBL] [Abstract][Full Text] [Related]
28. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices. Monnet FP; de Costa BR; Bowen WD Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of [125I]3'-(-)-iodopentazocine, a selective sigma 1 receptor ligand. Chien CC; Carroll FI; Brown GP; Pan YX; Bowen W; Pasternak GW Eur J Pharmacol; 1997 Mar; 321(3):361-8. PubMed ID: 9085049 [TBL] [Abstract][Full Text] [Related]
30. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. Moltzen EK; Perregaard J; Meier E J Med Chem; 1995 May; 38(11):2009-17. PubMed ID: 7783132 [TBL] [Abstract][Full Text] [Related]
31. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. Moebius FF; Bermoser K; Reiter RJ; Hanner M; Glossmann H Biochemistry; 1996 Dec; 35(51):16871-8. PubMed ID: 8988026 [TBL] [Abstract][Full Text] [Related]
32. Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503. Lever JR; Gustafson JL; Xu R; Allmon RL; Lever SZ Synapse; 2006 May; 59(6):350-8. PubMed ID: 16463398 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain. Benavides J; Peny B; Allen J; Scatton B J Pharmacol Exp Ther; 1992 Feb; 260(2):896-901. PubMed ID: 1310741 [TBL] [Abstract][Full Text] [Related]
34. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile. Karbon EW; Abreu ME; Erickson RH; Kaiser C; Natalie KJ; Clissold DB; Borosky S; Bailey M; Martin LA; Pontecorvo MJ J Pharmacol Exp Ther; 1993 May; 265(2):866-75. PubMed ID: 8388461 [TBL] [Abstract][Full Text] [Related]
35. [3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum. Zabetian CP; Staley JK; Flynn DD; Mash DC Life Sci; 1994; 55(20):PL389-95. PubMed ID: 7968220 [TBL] [Abstract][Full Text] [Related]
37. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain. Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488 [TBL] [Abstract][Full Text] [Related]
38. Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptors. Schepmann D; Frehland B; Lehmkuhl K; Tewes B; Wünsch B J Pharm Biomed Anal; 2010 Nov; 53(3):603-8. PubMed ID: 20462722 [TBL] [Abstract][Full Text] [Related]
39. The anticonvulsant actions of sigma receptor ligands in the Mg2+-free model of epileptiform activity in rat hippocampal slices. Thurgur C; Church J Br J Pharmacol; 1998 Jul; 124(5):917-29. PubMed ID: 9692777 [TBL] [Abstract][Full Text] [Related]
40. Inotropic action of sigma receptor ligands in isolated cardiac myocytes from adult rats. Novakova M; Ela C; Barg J; Vogel Z; Hasin Y; Eilam Y Eur J Pharmacol; 1995 Nov; 286(1):19-30. PubMed ID: 8566148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]